Search
for
Sort by
Research 391–420 of 1000+
- Epidermal E-Cadherin Dependent β-Catenin Pathway Is Phytochemical Inducible and Accelerates Anagen Hair Cycling
- Myristoleic Acid Promotes Anagen Signaling by Autophagy through Activating Wnt/β-Catenin and ERK Pathways in Dermal Papilla Cells
- Construction of transcriptome atlas of white yak hair follicle during anagen and catagen using single-cell RNA sequencing
- Limonin, a Component of Immature Citrus Fruits, Activates Anagen Signaling in Dermal Papilla Cells
- Effect of a Hydrolyzed Collagen, Vitamin, and Zinc Containing Nutritional Supplement on Telogen Effluvium
- Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
- Microneedles along with conventional therapies: An in-depth observational review in alopecia areata treatment
- Cyclic ADP-Ribose Modulates Intracellular Calcium Homeostasis and Anagen-Associated Signaling Pathways in Human Hair Follicle Dermal Papilla Cells
- Pathophysiology, conventional treatments, and evidence-based herbal remedies of hair loss with a systematic review of controlled clinical trials
- Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- Effect of Free Long-Chain Fatty Acids on Anagen Induction: Metabolic or Inflammatory Aspect?
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- Type II Epithelial Keratin 6hf (K6hf) Is Expressed in the Companion Layer, Matrix, and Medulla in Anagen-Stage Hair Follicles
- Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata – part II
- SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation
- Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial
- Mediator 1 ablation induces enamel-to-hair lineage conversion in mice through enhancer dynamics
- Beyond the Epidermal-Melanin-Unit: The Human Scalp Anagen Hair Bulb Is Home to Multiple Melanocyte Subpopulations of Variable Melanogenic Capacity
- Eavesdropping on the conversation between immune cells and the skin epithelium
- Alopécia Androgênica Feminina: Aspectos Hormonais E Tratamentos Integrativos.
- Medical Management Options for Hair Loss
- Bee Venom Promotes Hair Growth in Association with Inhibiting 5α-Reductase Expression
- Plasma Rich in Growth Factors as an Adjuvant Treatment for the Management of Frontal Fibrosing Alopecia: A Retrospective Observational Clinical Study
- From a stem-cell–centered to a niche-centered view: the core role of collagen networks in hair loss and hair follicle miniaturization
- Modulating hair follicle size with <i>Wnt10b/DKK1</i> during hair regeneration
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Topical L‐thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?
- Efficacy of 5% Minoxidil versus Combined 5% Minoxidil and 0.01% Tretinoin for Male Pattern Hair Loss
- Evaluation of retardant property of green hair growth retardant formula